论文部分内容阅读
通过对润湿分散剂、防冻剂、增稠剂的筛选,确定了15%甲维.吡虫啉悬浮剂优惠配方:78.2%甲维盐原药6.5%,95.6%吡虫啉原药10.6%,润湿分散剂GY-SC85 3.0%,防冻剂尿素4.0%,增稠剂黄原胶0.2%、硅酸镁铝0.5%,消泡剂GY-X60 0.2%,水75.0%。该优惠配方制备的悬浮剂低温和热贮后物理化学性质稳定。
Through the screening of wetting and dispersing agent, antifreeze and thickener, the prescription of 15% carbaryl imidacloprid suspension was determined as follows: preferential formula of 78.2% carbaryl salt raw material, 10.6% of 95.6% imidacloprid original drug, wet dispersion GY-SC85 3.0%, antifreeze urea 4.0%, thickener 0.2% xanthan gum, 0.5% magnesium aluminum silicate, defoamer GY-X60 0.2%, water 75.0%. The suspending agent prepared by the preferential formula has stable physicochemical properties under low temperature and after heat storage.